Evidence map›Paper›PMID 39011839›Full record

ArticleMolecular pharmaceutics2024

Coacervation in Slow Motion: Kinetics of Complex Micelle Formation Induced by the Hydrolysis of an Antibiotic Prodrug.

Thomas D Vogelaar, Szymon M Szostak, Reidar Lund

Abstract read
In one paragraph

Article in Molecular pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Thomas D VogelaarDepartment of Chemistry, University of Oslo, P.O. Box 1033 Blindern, Oslo NO-0315, Norway.ORCID 0000-0002-1653-1477
Szymon M SzostakDepartment of Chemistry, University of Oslo, P.O. Box 1033 Blindern, Oslo NO-0315, Norway.ORCID 0000-0002-3057-6225
Reidar LundDepartment of Chemistry, University of Oslo, P.O. Box 1033 Blindern, Oslo NO-0315, Norway.ORCID 0000-0001-8017-6396

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colistin methanesulfonate (CMS) is the less-toxic prodrug of highly nephrotoxic colistin. To develop and understand highly necessary new antibiotic formulations, the hydrolysis of CMS to colistin must be better understood. Herein, with the addition of poly(ethylene oxide)-b-poly(methacrylic acid) (PEO-b-PMAA) to CMS, we show that we can follow the hydrolysis kinetics, employing small-angle X-ray scattering (SAXS) through complex coacervation. During this hydrolysis, hydroxy methanesulfonate (HMS) groups from CMS are cleaved, while the newly formed cationic amino groups complex with the anionic charge from the PMAA block. As the hydrolysis of HMS groups is slow, we can follow the complex coacervation process by the gradual formation of complex micelles containing activated antibiotics. Combining mass spectrometry (MS) with SAXS, we quantify the hydrolysis as a function of pH. Upon modeling the kinetic pathways, we found that complexation only happens after complete hydrolysis into colistin and that the process is accelerated under acidic conditions. At pH = 5.0, effective charge switching was identified as the slowest step in the CMS conversion, constituting the rate-limiting step in colistin formation.

Indexed as

Anti-Bacterial AgentsColistinMicellesProdrugsScattering, Small AngleX-Ray DiffractionHydrogen-Ion ConcentrationHydrolysisKineticsPolyethylene GlycolsAnti-Bacterial AgentsColistinMicellesPolyethylene GlycolsProdrugsantibioticscolistin methanesulfonatedrug deliverymass spectrometrysmall-angle X-ray scattering

Identifiers

PMID39011839
PMCPMC11304390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.